Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance

Trends in Microbiology

Volumn 24, Issue 5, 2016, Pages 402-413

  Moya, Andrés ^a,b,c   Ferrer, Manuel ^d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d CSIC   (Spain)

Author keywords

Dysbiosis; Functional redundancy; Resilience; Resistance; Stability

Indexed keywords

RNA 16S;

BACTERIAL COLONIZATION; BACTEROIDES; BIFIDOBACTERIUM; BLAUTIA; CELL DIFFERENTIATION; CELL EXPANSION; CLOSTRIDIUM; DYSBIOSIS; FAECALIBACTERIUM; GENE EXPRESSION PROFILING; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; INSULIN SENSITIVITY; INTESTINE FLORA; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL GENE; MOLECULAR DYNAMICS; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PREVOTELLA; PRIORITY JOURNAL; REVIEW; RUMINOCOCCUS; ANIMAL; BIODIVERSITY; BIOTA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BIODIVERSITY; BIOTA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS;

EID: 84961223855     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.02.002     Document Type: Review

References (74)

1. Moya A., et al. Learning how to live together: genomic insights into prokaryote-animal symbioses. Nat. Rev. Genet. 2008, 9:218-229.
2. Gevers D., et al. The human microbiome project: a community resource for the healthy human microbiome. PLoS Biol. 2012, 10:e1001377.
3. McFall-Ngai M. Divining the essence of symbiosis: insights from the Squid-Vibrio model. PLoS Biol. 2014, 12:e1001783.
4. Vallès Y., et al. Microbial succession in the gut: Directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet. 2014, 10:e1004406.
5. The Strategy of the Genes. A Discussion of Some Aspects of Theoretical Biology 1957, George Allen and Unwin. C.H. Waddington (Ed.).
6. Faust K., et al. Metagenomics meets time series analysis: unraveling microbial community dynamics. Curr. Opin. Microbiol. 2015, 25:56-66.
7. Lepage P., et al. A metagenomic insight into our gut's microbiome. Gut 2013, 62:146-158.
8. Pérez-Cobas A.E., et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013, 62:1591-1601.
9. Larsen P.E., Dai Y. Metabolome of human gut microbiome is predictive of host dysbiosis. GigaScience 2015, 4:42.
10. Shoaie S., et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metabolism 2015, 22:320-331.
11. Faith J.J., et al. The long-term stability of the human gut microbiota. Science 2013, 341:1237439.
12. Shin N.R., et al. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015, 33:496-503.
13. Potgieter M., et al. The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol. Rev. 2015, 39:567-591.
14. Allison S.D., Martiny J.B.H. Resistance, resilience, and redundancy in microbial communities. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11512-11519.
15. Lozupone C.A., et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230.
16. Comte J., et al. Links between metabolic plasticity and functional redundancy in freshwater bacterioplankton communities. Front. Microbiol. 2013, 4:112.
17. Ha C.W., et al. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J. Gastroenterol. 2014, 20:16498-16517.
18. Keller A., et al. Computational integration of genomic traits into 16S rDNA microbiota sequencing studies. Gene 2014, 549:186-191.
19. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
20. Chen J., et al. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics 2012, 28:2106-2113.
21. Yatsunenko T., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
22. Li J., et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 2014, 32:834-841.
23. Zhu A., et al. Inter-individual differences in the gene content of human gut bacterial species. Genome Biol. 2015, 16:82.
24. Cotillard A., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
25. Smith M.I., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013, 339:548-554.
26. David L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
27. Rojo D., et al. Ranking the impact of human health disorders on gut metabolism: systemic lupus erythematosus and obesity as study cases. Sci. Rep. 2015, 5:8310.
28. Seksik P., Landman C. Understanding microbiome data: a primer for clinicians. Dig. Dis. 2015, 33(SUPPL. 1):11-16.
29. Miki T., et al. Biodiversity and multifunctionality in a microbial community: a novel theoretical approach to quantify functional redundancy. Proc. R. Soc. B 2014, 281:20132498.
30. Purahong W., et al. Uncoupling of microbial community structure and function in decomposing litter across beech forest ecosystems in Central Europe. Sci. Rep. 2014, 4:7014.
31. Burke C., et al. Bacterial community assembly based on functional genes rather than species. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14288-14293.
32. Lennon J.T., Jones S.E. Microbial seed banks: the ecological and evolutionary implications of dormancy. Nat. Rev. Microbiol. 2011, 9:119-130.
33. Dapa T., et al. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J. Bacteriol. 2013, 195:545-555.
34. McNulty N.P., et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011, 3:106ra106.
35. Maurice C.F., et al. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013, 152:39-50.
36. Joyce S.A., et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7421-7426.
37. Nielsen U.N., et al. Soil biodiversity and carbon cycling: a review and synthesis of studies examining diversity-function relationships. Eur. J. Soil Sci. 2011, 62:105-116.
38. Ferrer M., et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ. Microbiol. 2013, 15:211-226.
39. Hernández E., et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 2013, 4:306-315.
40. Zhang C., et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2015, 4:232-241.
41. Bindels L.B., et al. Gut microbiota-derived propionate reduces cancer cell proliferation in liver. Br. J. Cancer 2012, 107. 1377-1344.
42. Furusawa Y., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
43. Louis P., et al. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12:661-672.
44. Vital M., et al. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014, 5:e00889.
45. Labbé A., et al. Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes. PLoS ONE 2014, 9:e115175.
46. Sokol H., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:16731-16736.
47. Morgan X.C., et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol. 2015, 16:67.
48. Ohland C.L., Jobin C. Microbial activities and intestinal homeostasis: A delicate balance between health and disease. Cell Mol. Gastroenterol. Hepatol. 2015, 1:28-40.
49. Larsen N., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 2010, 5:e9085.
50. Org E., et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 2015, 25:1558-1569.
51. Degnan P.H., et al. Human gut microbes use multiple transporters to distinguish vitamin B12 analogs and compete in the gut. Cell Host Microbe. 2014, 15:47-57.
52. Broz P., et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 2010, 207:1745-1755.
53. Rojo D., et al. Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses. ISME J. 2015, 9:2206-2220.
54. Modi S.R., et al. Antibiotics and the gut microbiota. J. Clin. Invest. 2015, 124:4212-4218.
55. Nylund L., et al. Intestinal microbiota during early life - impact on health and disease. Proc. Nutr. Soc. 2014, 73:457-469.
56. Bäckhed F., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015, 17:690-703.
57. Claesson M.J., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl 1):4586-4591.
58. Cohen L.J., et al. Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. Proc. Natl. Acad. Sci. U.S.A. 2015, 112:E4825-E4834.
59. Qin N., et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 2014, 513:59-64.
60. Hevia A., et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 2014, 5:e01548-e1614.
61. Fijlstra M., et al. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model. Support. Care Cancer 2015, 23:1513-1522.
62. Pérez-Cobas A.E., et al. Structural and functional changes in the gut microbiota associated to Clostridium difficile infection. Front. Microbiol. 2014, 5:335.
63. Vázquez-Castellanos J.F., et al. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol. 2014, 8:760-772.
64. Morgan X.C., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13:R79.
65. Arthur J.C., et al. Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat. Commun. 2014, 5:4724.
66. Pyra K.A., et al. Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. J. Nutr. 2012, 142:213-220.
67. Dejea C.M., et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:18321-18326.
68. Zeller G., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 2014, 10:766.
69. Rooks M.G., et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 2014, 8:1403-1417.
70. Cox L.M., Blaser M.J. Pathways in microbe-induced obesity. Cell Metab. 2013, 17:883-894.
71. Subramanian S., et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 2014, 510:417-421.
72. El Aidy S., et al. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut 2013, 62:1306-1314.
73. Ng K.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
74. Marcobal A., et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 2013, 7:1933-1943.